SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-06-042753
Filing Date
2006-06-21
Accepted
2006-06-20 20:31:32
Documents
5
Period of Report
2006-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-14083_18k.htm 8-K 32418
2 EX-3 a06-14083_1ex3di.htm EX-3.I 338595
3 EX-10 a06-14083_1ex10d1.htm EX-10.1 94754
4 EX-99 a06-14083_1ex99d1.htm EX-99.1 11940
5 GRAPHIC g140831mai001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-06-042753.txt   483469
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 06916220
SIC: 2835 In Vitro & In Vivo Diagnostic Substances